Cetera Advisor Networks’s Avenue Therapeutics ATXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-10
Closed -$3K – 2191
2022
Q2
$3K Buy
+10
New +$3.85K ﹤0.01% 2055

Other funds holding ATXI

Cetera Advisor Networks's ATXI Position: Q3 2022 in Review

Cetera Advisor Networks sold out of Avenue Therapeutics (ATXI) in Q3 2022, closing a stake of 10 shares — an estimated $3K sold.

Cetera Advisor Networks first reported a position in ATXI in Q2 2022 and held it in 1 quarter. The position peaked at $3K in Q2 2022. 10 funds tracked by Wall St. Rank hold ATXI as of Q3 2022.

  • Cetera Advisor Networks reported no remaining Avenue Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Cetera Advisor Networks sold 10 Avenue Therapeutics shares in Q3 2022, an estimated $3K.
  • Cetera Advisor Networks first reported a position in Avenue Therapeutics in Q2 2022 and held it in 1 quarter.
  • Cetera Advisor Networks's Avenue Therapeutics position peaked at $3K in Q2 2022.
  • 10 funds tracked by Wall St. Rank held Avenue Therapeutics as of Q3 2022.

Based on Cetera Advisor Networks's 13F filing for Q3 2022, filed 14 Nov 2022.